Merlin S, Akula S, Cottonaro A, Garcia-Leal T, Serrano LJ, Borroni E, Kalandadze V, Galiano R, Borsotti C, Liras A, Sanchez MJ*, Follenzi A*. (2023). Therapeutic potential of fetal liver cell transplantation in hemophilia a mice. Haematologica, 108: 1544-1554. *principal investigators, corresponding authors.
De Pablo-Moreno J, Serrano JL, Revuelta L, Sánchez MJ*, Liras A*. (2022). The vascular endothelium and coagulation: Homeostasis, Disease and treatment, with a focus on the Von Wilibrand factor, factors FVIII and FV. Int. J. Mol. Sci. 23:8283-8294. *principal investigators, corresponding authors.
Hombría Castelli-Gair J, Sánchez MJ (2021). Translation of the book on CRISPR technology by the Nobel laureated J Doubna and S Sternberg: "A crack in creation: gene editing and the unthinkable power to control evolution". "Una grieta en la creación. CRISPR, la edición génica y el increíble poder de controlar la evolución. ISBM 978-84-918-887-8, Alianza Editorial.
Serrano Ramos LJ, Cañete A, Garcia-Leal T, Tomas-Gallardo L, Flores AI, De la Torre P, Liras A and Sanchez MJ. (2018). Searching for a cellbased therapeutic tool for haemophilia A within the embryonic foetal liver and the aortagonads- mesonephros (AGM) region. Throm&Haem, 118: 1370-1381.
Cañete-Sánchez, Ana; Carmona-Megias, Rita; Ariza, Laura;Sanchez-Sanz, Maria Jose; Rojas, Anabel; Muñoz-Chapuli-Oriol, Ramon. (2017). A population of hematopoietic stem cells derives from GATA4-expressing progenitors located in the placenta and lateral mesoderm of mice. Haematologica. 102: 647-655.
Cañete A, Comaills V, Prados I, Castro AM, Hammad S, Ybot-Gonzalez P, Bockamp E, Hengstler JG, Gottgens B, Sanchez MJ. (2017). Characterization of a Fetal Liver Cell Population Endowed with Long-Term Multiorgan Endothelial Reconstitution Potential. Stem Cells. 35: 507-521.
Wilkinson AC, Goode DK, Cheng YH, Dickel DE, Foster S, Sendall T, Tijssen MR, Sanchez MJ, Pennacchio LA, Kirkpatrick AM, Gottgens B. (2013). Single site-specific integration targeting coupled with embryonic stem cell differentiation provides a high-throughput alternative to in vivo enhancer analyses. Biol Open 2: 1229-38.
Garcia-Ortega AM, Canete A, Quinter C, Silberstein L, Piquer-Gil M, Alvarez-Dolado M, Dekel B, Gottgens B, Sanchez M.J. (2010). Enhanced hematovascular contribution of SCL 3' enhancer expressing fetal liver cells uncovers their potential to integrate in extramedullary adult niches. Stem Cells 28: 100-12.